AAOF Clinical Podcast Series

Recent Episodes

Lotilaner Ophthalmic Solution, 0.25% for Demodex Blepharitis: Phase 3 Trial (Saturn-2)

Posted February 23, 2024 • 00:06:04

Lotilaner Ophthalmic Solution, 0.25% for Demodex Blepharitis: Randomized, Vehicle- Controlled, Multicenter, Phase 3 Trial (Saturn-2) Hosted by: Andrew...

Lotilaner Ophthalmic Solution, 0.25%, for Treatment of Demodex Blepharitis: Trial Results (Saturn-1)

Posted February 23, 2024 • 00:07:55

Lotilaner Ophthalmic Solution, 0.25%, for the Treatment of Demodex Blepharitis: Results of a Prospective, Randomized, Vehicle-Controlled, Double-Masked,...

Prescribing Patterns of Myopia Control Contact Lenses among Optometrists in Ireland

Posted February 22, 2024 • 00:09:54

...

Further Validation of Comfortable Print Size as a Parameter for Clinical Low Vision Assessment

Posted January 11, 2024 • 00:10:44

...

Management of Keratoconus with repeated use of Conrieal Crosslinking

Posted January 11, 2024 • 00:07:25

...